
vaccines


EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe
The European Commission authorised the use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds on Friday, following the European Medicines Agency's approval of administering the jabs to adolescents earlier in the day.